Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells
暂无分享,去创建一个
Sandrine Mendes | Cláudia Lobato da Silva | Mário Grãos | M. Grãos | J. Cabral | P. Andrade | C. L. da Silva | J. Cabral | Carla M. P. Cardoso | P. Laranjeira | A. Paiva | A. Ribeiro | S. Mendes | I. Velada | Cristiana Leite | F. Santos | A. Henriques | A. Martinho | M. Pais | H. Trindade | Andreia Ribeiro | Paula Laranjeira | Isabel Velada | Cristiana Leite | Pedro Andrade | Francisco Santos | Ana Henriques | Carla M P Cardoso | António Martinho | MLuísa Pais | Joaquim Cabral | Hélder Trindade | Artur Paiva | A. Paiva | Pedro Z. Andrade | Sandrine Mendes | Carla M Cardoso
[1] G. Gilkeson,et al. Allogenic Mesenchymal Stem Cell Transplantation Ameliorates Nephritis in Lupus Mice via Inhibition of B-Cell Activation , 2013, Cell transplantation.
[2] E. Haddad,et al. Cord-blood-derived mesenchymal stromal cells downmodulate CD4+ T-cell activation by inducing IL-10-producing Th1 cells. , 2013, Stem cells and development.
[3] Z. Zhao,et al. The Different Immunoregulatory Functions on Dendritic Cells between Mesenchymal Stem Cells Derived from Bone Marrow of Patients with Low-Risk or High-Risk Myelodysplastic Syndromes , 2013, PloS one.
[4] X. Luan,et al. Human placenta-derived mesenchymal stem cells suppress T cell proliferation and support the culture expansion of cord blood CD34⁺ cells: a comparison with human bone marrow-derived mesenchymal stem cells. , 2013, Tissue & cell.
[5] F. Djouad,et al. Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway , 2012, Journal of Translational Medicine.
[6] B. Akgül,et al. Aggregatibacter actinomycetemcomitans GroEL Protein Promotes Conversion of Human CD4+ T Cells into IFNγ IL10 Producing Tbet+ Th1 Cells , 2012, PloS one.
[7] M. Toungouz,et al. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes. , 2012, Immunology letters.
[8] H. Tse,et al. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis , 2012, Allergy.
[9] P. Laranjeira,et al. Immunophenotypic Characterization of Normal Bone Marrow Stem Cells , 2012 .
[10] E. Lombardo,et al. Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. , 2012, Stem cells and development.
[11] W. Weimar,et al. On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation , 2012, Front. Immun..
[12] J. Grinyó,et al. Immunomodulatory Effect of Mesenchymal Stem Cells on B Cells , 2012, Front. Immun..
[13] B. Xia,et al. CD4+T Cells: Differentiation and Functions , 2012, Clinical & developmental immunology.
[14] A. Venditti,et al. CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study , 2012, Haematologica.
[15] Lieping Chen,et al. B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation , 2012, PloS one.
[16] K. Pramanik,et al. Immunomodulatory Properties of Mesenchymal Stem Cells: Cytokines and Factors , 2012, American journal of reproductive immunology.
[17] Yuhong Yang,et al. TGF‐β signaling via Smad4 drives IL‐10 production in effector Th1 cells and reduces T‐cell trafficking in EAE , 2011, European journal of immunology.
[18] S. Morbelli,et al. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells , 2011, Proceedings of the National Academy of Sciences.
[19] S. Chouaib,et al. Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. , 2011, Blood.
[20] T. Ritter,et al. Mesenchymal stem cell effects on T-cell effector pathways , 2011, Stem Cell Research & Therapy.
[21] Huey-Kang Sytwu,et al. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells , 2011, Journal of Biomedical Science.
[22] E. Andreeva,et al. Subpopulation Composition and Activation of T Lymphocytes during Coculturing with Mesenchymal Stromal Cells in Medium with Different O2 Content , 2011, Bulletin of Experimental Biology and Medicine.
[23] Kazuya Sato,et al. Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation. , 2011, Cytotherapy.
[24] M. Zago,et al. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes. , 2011, Stem cell research.
[25] K. Klotz,et al. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity , 2011, Cancer Immunology, Immunotherapy.
[26] Z. Madeja,et al. Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice. , 2011, Experimental hematology.
[27] A. Durrbach,et al. Long-Lasting Inhibitory Effects of Fetal Liver Mesenchymal Stem Cells on T-Lymphocyte Proliferation , 2011, PloS one.
[28] E. Chernykh,et al. Multiplex Analysis of Cytokines, Chemokines, Growth Factors, MMP-9 and TIMP-1 Produced by Human Bone Marrow, Adipose Tissue, and Placental Mesenchymal Stromal Cells , 2011, Bulletin of Experimental Biology and Medicine.
[29] F. Carrión,et al. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation. , 2011, Immunology letters.
[30] M. van Griensven,et al. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. , 2011, Stem cells and development.
[31] Xia Li,et al. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study , 2011, Frontiers of medicine.
[32] B. Cochran. STAT3 (signal transducer and activator of transcription 3) , 2011 .
[33] Shinn-Zong Lin,et al. Mesenchymal Stem Cells , 2011, Cell transplantation.
[34] N. Câmara,et al. Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand? , 2011, World journal of stem cells.
[35] A. Caplan,et al. Mesenchymal stem cells: mechanisms of inflammation. , 2011, Annual review of pathology.
[36] Gabriel Courties,et al. IL-6-Dependent PGE2 Secretion by Mesenchymal Stem Cells Inhibits Local Inflammation in Experimental Arthritis , 2010, PloS one.
[37] A. Cutler,et al. Umbilical Cord-Derived Mesenchymal Stromal Cells Modulate Monocyte Function to Suppress T Cell Proliferation , 2010, The Journal of Immunology.
[38] R. Yañez,et al. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. , 2010, Experimental cell research.
[39] R. Handgretinger,et al. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. , 2010, Blood.
[40] T. Ritter,et al. Immunological aspects of allogeneic mesenchymal stem cell therapies. , 2010, Human gene therapy.
[41] M. Toungouz,et al. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. , 2010, Experimental hematology.
[42] A. Martini,et al. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. , 2010, Arthritis and rheumatism.
[43] M. Toungouz,et al. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. , 2010, Tissue engineering. Part A.
[44] P. Menasché,et al. Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell. , 2010, Stem cells and development.
[45] C. Jorgensen,et al. Mesenchymal Stem Cells Inhibit Human Th17 Cell Differentiation and Function and Induce a T Regulatory Cell Phenotype , 2010, The Journal of Immunology.
[46] Steven J. Greco,et al. Mesenchymal Stem Cells Protect Breast Cancer Cells through Regulatory T Cells: Role of Mesenchymal Stem Cell-Derived TGF-β , 2010, The Journal of Immunology.
[47] Xiaodong Chen,et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair , 2010, Cell Research.
[48] A. Boudabous,et al. Evidence for the Involvement of Galectin‐3 in Mesenchymal Stem Cell Suppression of Allogeneic T‐Cell Proliferation , 2010, Scandinavian journal of immunology.
[49] F. Djouad,et al. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications , 2010, Stem Cell Research & Therapy.
[50] Shilpa Shankar,et al. Pro-Inflammatory Cytokines, IFNγ and TNFα, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially , 2010, PloS one.
[51] X. Luan,et al. The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity. , 2010, Stem cells and development.
[52] Cláudia Lobato da Silva,et al. Ex vivo expansion of human mesenchymal stem cells: A more effective cell proliferation kinetics and metabolism under hypoxia , 2009, Journal of cellular physiology.
[53] C. Thiemermann,et al. Mesenchymal Stromal Cells: Current Understanding and Clinical Status , 2009, Stem cells.
[54] A. Reinisch,et al. Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs). , 2009, Journal of visualized experiments : JoVE.
[55] Yang Li,et al. [Effect of mesenchymal stem cells on expression of CD69 in cord blood CIK/NK cells and quantity ratio of T regulatory cells in CIK/NK cell culture]. , 2009, Zhongguo shi yan xue ye xue za zhi.
[56] Zhenping Chen,et al. Fetal BM‐derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells , 2009, European journal of immunology.
[57] Min-jung Park,et al. Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10 , 2009, Experimental & Molecular Medicine.
[58] S. Itakura,et al. Mesenchymal stem cells suppress B-cell terminal differentiation. , 2009, Experimental hematology.
[59] José F. M. Morgado,et al. Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. , 2009, Transplantation proceedings.
[60] M. Yen,et al. Brief Report—Human Embryonic Stem Cell‐Derived Mesenchymal Progenitors Possess Strong Immunosuppressive Effects Toward Natural Killer Cells as Well as T Lymphocytes , 2009, Stem cells.
[61] S. Feng,et al. Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury , 2009, Chinese medical journal.
[62] M. Tremblay,et al. Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. , 2008, Blood.
[63] J. Ryan,et al. Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non‐redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells , 2008, Clinical and experimental immunology.
[64] B. Blanco,et al. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes , 2008, Haematologica.
[65] H. Klingemann,et al. Mesenchymal Stem Cells – Sources and Clinical Applications , 2008, Transfusion Medicine and Hemotherapy.
[66] Mohamed H. Sayegh,et al. Immunomodulation by Mesenchymal Stem Cells , 2008, Diabetes.
[67] E. Shankar,et al. Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines. , 2008, World journal of gastroenterology.
[68] S. Kyurkchiev,et al. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen‐stimulated B‐cell immunoglobulin production in vitro , 2008, Cell biology international.
[69] David M. Conrad,et al. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). , 2008, International journal of oncology.
[70] R. Zhao,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell stem cell.
[71] L. Moretta,et al. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. , 2008, Blood.
[72] N. Rouas-Freiss,et al. Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells , 2008, Stem cells.
[73] L. Cosmi,et al. Toll‐Like Receptors 3 and 4 Are Expressed by Human Bone Marrow‐Derived Mesenchymal Stem Cells and Can Inhibit Their T‐Cell Modulatory Activity by Impairing Notch Signaling , 2008, Stem cells.
[74] A. Nauta,et al. Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.
[75] Giselle Chamberlain,et al. Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing , 2007, Stem cells.
[76] L. Fouillard,et al. Immunosuppressive Effects of Mesenchymal Stem Cells: Involvement of HLA-G , 2007, Transplantation.
[77] A. Poggi,et al. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. , 2007, Haematologica.
[78] Lingyun Sun,et al. Polarization of T Lymphocytes Is Regulated by Mesenchymal Stem Cells in NZBWF1 and BALB/c Mice , 2007, International Journal of Molecular Sciences.
[79] O. Ringdén,et al. Mesenchymal Stem Cells Stimulate Antibody Secretion in Human B Cells , 2007, Scandinavian journal of immunology.
[80] R. Tuan,et al. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation , 2007, Arthritis research & therapy.
[81] G. Prendergast,et al. Indoleamine 2,3-dioxygenase in immune suppression and cancer. , 2007, Current cancer drug targets.
[82] A. Cometa,et al. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[83] X. Chen,et al. Mesenchymal stem cells in immunoregulation , 2006, Immunology and cell biology.
[84] J. V. van Laar,et al. Adult stem cells in the treatment of autoimmune diseases. , 2006, Rheumatology.
[85] A. Uccelli,et al. Immunoregulatory function of mesenchymal stem cells , 2006, European journal of immunology.
[86] M. Faronato,et al. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. , 2006, Blood.
[87] S. Perez,et al. Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells , 2006, Stem cells.
[88] G. Mancardi,et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. , 2005, Blood.
[89] Frank P Barry,et al. Mesenchymal stem cells avoid allogeneic rejection , 2005, Journal of Inflammation.
[90] R. Cancedda,et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway , 2005, European journal of immunology.
[91] O. Ringdén,et al. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. , 2005, Experimental cell research.
[92] M. Pittenger,et al. Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.
[93] O. Ringdén,et al. Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin‐2 Receptor) and CD38 on Phytohaemagglutinin‐Activated Lymphocytes , 2004, Scandinavian journal of immunology.
[94] O. Ringdén,et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells , 2003, Transplantation.
[95] M. Krampera,et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. , 2003, Blood.
[96] E. Guinan,et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation , 2003, Transplantation.
[97] Xiao-Jie Yan,et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. , 2002, Blood.
[98] C. Carlo-Stella,et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.
[99] G. Sukhikh,et al. Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.
[100] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[101] J. Tomaz,et al. Functional aspects of cord blood lymphocytes response to polyclonal and allogeneic activation. , 1998, Bone marrow transplantation.
[102] N. Pellis,et al. Suppressed PHA activation of T lymphocytes in simulated microgravity is restored by direct activation of protein kinase C , 1998, Journal of leukocyte biology.
[103] P. Simms,et al. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation , 1996, Clinical and Diagnostic Laboratory Immunology.
[104] G. Trinchieri,et al. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells , 1996, The Journal of experimental medicine.
[105] M. Norcross,et al. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. , 1995, Blood.
[106] A. Singer,et al. Similar co-stimulation requirements of CD4+ and CD8+ primary T helper cells: role of IL-1 and IL-6 in inducing IL-2 secretion and subsequent proliferation. , 1992, International immunology.
[107] M. Loeffler,et al. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. , 1990, Development.
[108] L. Davis,et al. Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation. , 1988, Journal of immunology.
[109] L. Davis,et al. Comparative effects of tumor necrosis factor-α and IL-1β on mitogen-induced T cell activation , 1988 .
[110] P. Lipsky,et al. Inhibition of human B cell responsiveness by prostaglandin E2. , 1987, Journal of immunology.
[111] P. Lipsky,et al. Regulation of human B cell proliferation by prostaglandin E2. , 1984, Journal of immunology.
[112] Jacques Galipeau,et al. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[113] M. Kolácková,et al. CD200/CD200R paired potent inhibitory molecules regulating immune and inflammatory responses; Part I: CD200/CD200R structure, activation, and function. , 2012, Acta medica.
[114] M. Toungouz,et al. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. , 2010, Cellular immunology.
[115] P. Martiat,et al. Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. , 2009, Cytotherapy.
[116] H. Koo,et al. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. , 2009, Cellular immunology.
[117] L. Moretta,et al. T.6. Mesenchymal Stem Cells Inhibit Natural Killer Cell Proliferation, Cytotoxicity and Cytokine Production: Role of Indoleamine 2,3-Dioxygenase and Prostaglandin E2 , 2009 .
[118] R. Ramasamy,et al. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. , 2008, Cellular immunology.
[119] J. Stagg. Immune regulation by mesenchymal stem cells: two sides to the coin. , 2007, Tissue antigens.
[120] R. Tuan,et al. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation , 2007 .
[121] G. Sukhikh,et al. Differentiation potential of mesenchymal stem cells of different origin , 2006, Bulletin of Experimental Biology and Medicine.
[122] F. Benvenuto,et al. Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.
[123] A. Cometa,et al. Inherited thrombocytopenias: from genes to therapy , 1994 .
[124] F. Guilak,et al. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. , 2003, Cytotherapy.
[125] 生越喬二. HLA(human leukocyte antigen) , 2002 .
[126] J. Ceuppens,et al. Accessory cell-derived helper signals in human T-cell activation with phytohemagglutinin: induction of interleukin 2-responsiveness by interleukin 6, and production of interleukin 2 by interleukin 1 [corrected]. , 1990, Cytokine.